CNS Radiation-Related Adverse Events in Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors

被引：0
|
作者：
Hubbeling, H. [1 ]
Schapira, E. [1 ]
Shaw, A. [1 ]
Oh, K. S. [1 ]
Gainor, J. [1 ]
Shih, H. A. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.349
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
324
引用
收藏
页码：S150 / S151
页数：2
相关论文
共 50 条
  • [1] Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors
    Chen, Juan
    Liu, Jia-Si
    Liu, Jun-Yan
    She, Lei
    Zou, Ting
    Yang, Fan
    Li, Xiang-Ping
    Wang, Zhan
    Liu, Zhaoqian
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (07) : 1 - 10
  • [2] Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors
    Yoon, Jee Hee
    Hong, A. Ram
    Kim, Hee Kyung
    Kang, Ho-Cheol
    [J]. ENDOCRINOLOGY AND METABOLISM, 2021, 36 (02) : 413 - 423
  • [3] Ocular adverse events in PD-1 and PD-L1 inhibitors
    Young, LeAnne
    Finnigan, Shanda
    Streicher, Howard
    Chen, Helen X.
    Murray, James
    Sen, H. Nida
    Sharon, Elad
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
  • [4] Herpes zoster in lung cancer patients treated with PD-1/PD-L1 inhibitors
    Taoka, Masataka
    Ochi, Nobuaki
    Yamane, Hiromichi
    Yamamoto, Takenobu
    Kawahara, Tatsuyuki
    Uji, Emiko
    Kosaka, Youko
    Takeda, Kouhei
    Nagasaki, Yasunari
    Nakanishi, Hidekazu
    Aoyama, Yumi
    Takigawa, Nagio
    [J]. TRANSLATIONAL CANCER RESEARCH, 2022, 11 (03) : 456 - 462
  • [5] Imaging evaluation of lung cancer treated with PD-1/PD-L1 inhibitors
    Mohammed, Nader
    Zhou, Rong Rong
    Xiong, Zeng
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1127):
  • [6] Pleural or pericardial metastasis: A significant factor affecting efficacy and adverse events in lung cancer patients treated with PD-1/PD-L1 inhibitors
    Kang, Da Hyun
    Chung, Chaeuk
    Kim, Ju-Ock
    Jung, Sung Soo
    Park, Hee Sun
    Park, Dong Il
    Jung, Sun Young
    Park, Myoungrin
    Lee, Jeong Eun
    [J]. THORACIC CANCER, 2018, 9 (11) : 1500 - 1508
  • [7] Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors
    Zhang, You-Cheng
    Zhu, Tian-Chen
    Nie, Run-Cong
    Lu, Liang-He
    Xiang, Zhi-Cheng
    Xie, Dan
    Luo, Rong-Zhen
    Cai, Mu-Yan
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
  • [8] Immune-related thyroid dysfunction in lung cancer patients treated with PD-1/PD-L1 checkpoint inhibitors
    Bulusu, Venkata
    Jessop, Susan
    Paul, Sherin
    Chapman, Timothy
    Aslam, Shahzeena
    Jeffs, Yvonne
    Punnen, Geethu
    Geetha, Anil
    Hutka, Margaret
    [J]. LUNG CANCER, 2023, 178 : S30 - S30
  • [9] Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
    Griewing, Luisa Maria
    Schweizer, Claudia
    Schubert, Philipp
    Rutzner, Sandra
    Eckstein, Markus
    Frey, Benjamin
    Haderlein, Marlen
    Weissmann, Thomas
    Semrau, Sabine
    Gostian, Antoniu-Oreste
    Mueller, Sarina K.
    Traxdorf, Maximilian
    Iro, Heinrich
    Zhou, Jian-Guo
    Gaipl, Udo S.
    Fietkau, Rainer
    Hecht, Markus
    [J]. BMC CANCER, 2021, 21 (01)
  • [10] Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian Populations
    Yang, Jiqiao
    He, Xiujing
    Lv, Qing
    Jing, Jing
    Shi, Hubing
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
12345